No trading implications from this filing. Monitor for any unexpected director changes or auditor issues, but this appears to be a standard annual meeting with no surprises.
VKTX drugs
VKTX drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 2 $34.80entry
- T+1 · 8mo ago −2.50%α −2.98% · $33.93
- T+5 · 7mo ago −1.55%α −5.17% · $34.26
- T+20 · 7mo ago −10.40%α −20.28% · $31.18
- T+60 · 5mo ago +12.10%α −2.06% · $39.01
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Viking Therapeutics is holding its 2026 annual shareholder meeting to vote on director elections, auditor selection, and executive compensation. This is a routine annual filing with no material financial or operational updates.
Key Financial Metrics
Key Facts
- Annual shareholder meeting scheduled for May 19, 2026
- Voting on election of two Class II directors: J. Matthew Singleton and S. Kathryn Rouan, Ph.D.
- Ratification of CBIZ CPAS P.C. as independent auditors
- Advisory vote on executive compensation
- Board recommends approval of all proposals
Financial Impact
No immediate financial impact - routine governance matters
Risk Factors
- None identified in this filing
- Standard risks associated with any corporate governance vote
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-137924 |
| Document: 0001193125-26-137924-index-headers.html | 0001193125-26-137924 |
| Document: 0001193125-26-137924-index.html | 0001193125-26-137924 |
| Document: 0001193125-26-137924.txt | 0001193125-26-137924 |
Track record
13 reports on VKTX
5 of 5 bullish or bearish reports moved the stock their way by T+1. Best: +31.38% at T+20 after the Sep 24, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $25.79 to $26.84 Now $26.80 +3.92% ▲ +4.07% +3.76% vs SPY
- Oct 28, 202619d ago 8-K Neutral 5/10 Entry $26.86 to $27.28 Now $26.80 −0.22% ▲ +1.56% +3.34% vs SPY
- Oct 23, 202624d ago Institutional Cluster Bearish 4/10 Entry $24.40 to $24.21 Now $26.80 −9.84% ▲ +0.78% +1.49% vs SPY
- Oct 21, 202626d ago Press Release Neutral 1/10 Entry $25.83 to $24.40 Now $26.80 +3.76% ▼ −5.54% −5.01% vs SPY
- Sep 28, 20267w ago 8-K Mixed 6/10 Entry $31.81 to $32.60 Now $26.80 −15.75% ▲ +2.48% +2.69% vs SPY
- Sep 24, 20267w ago 424B5 Bearish 5/10 Entry $35.56 to $33.03 Now $26.80 +24.63% ▲ +7.11% +6.37% vs SPY
- Sep 24, 20267w ago 424B5 Bearish 6/10 Entry $35.56 to $33.03 Now $26.80 +24.63% ▲ +7.11% +6.37% vs SPY
- Sep 23, 20267w ago 424B5 Neutral 4/10 Entry $36.75 to $35.56 Now $26.80 −27.07% ▼ −3.24% −3.78% vs SPY
- Sep 23, 20267w ago 424B5 Bearish 6/10 Entry $36.75 to $35.56 Now $26.80 +27.07% ▲ +3.24% +3.78% vs SPY
- Sep 22, 20267w ago 8-K Bullish 7/10 Entry $40.85 to $41.65 Now $26.80 −34.39% ▲ +1.96% +2.68% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers